CHMP Delays Review of Portola's Ondexxya; Who Will Pass Muster?

 
• By Maureen Kenny
  
Beneftis vs Risks
A positive benefit-risk balance is critical if a new drug is to secure approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography